Position in ABSI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$788,790
+$541,221 QoQ
Shares Held
68,058
-17.5% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#93
of 195 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in ABSI Over Time
Shares Held
Position Value (USD)
Derivatives in ABSI
reported options exposure · as of Jun 30, 2026CallValue
$711,626
CallShares
61,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,204,586 across 455 Biotechnology names. ABSI ranks #130 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in ABSI
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $711,626 | 61,400 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $788,790 | 68,058 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $247,569 | 82,523 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,776,416 | 509,002 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $715,555 | 235,380 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $511,113 | 198,877 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $262,435 | 104,556 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $344,828 | 131,614 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $502,344 | 131,504 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $84,455 | 27,421 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $409,590 | 72,111 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $466 | 111 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $293 | 222 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $168 | 111 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $47,050 | 26,886 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $29,926 | 14,251 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $6,989 | 2,233 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $29,521 | 8,892 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $146,892 | 17,425 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||